$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
What kind of drugs does Asnib/Assiminib (Xinbeli) belong to and its clinical classification analysis
2026-02-01 22:25:32
Check Details
Clinical efficacy and evaluation of ritexitinib (Lefenox) in the treatment of vitiligo
2026-02-01 22:25:32
Check Details
The latest market price and reference cost of sparsentan (sparsentan) per box
2026-02-01 22:25:32
Check Details
Analysis on whether long-term medication must be adhered to after taking Ixazomib (Enleri)
2026-02-01 22:25:32
Check Details
The latest market price and reference cost of each tube of Lurbinectedin
2026-02-01 22:25:32
Check Details
Whether Anagrelide has been officially launched in the country and the relevant approval progress
2026-02-01 22:25:32
Check Details
Common side effects of apalutamide (Ansenko) and how to deal with adverse reactions
2026-02-01 22:25:32
Check Details
Differences and comparisons in efficacy and indications between Elacetrant and Fulvestrant
2026-02-01 22:25:32
Check Details
Can F/TAF be used for 211 post-exposure prophylaxis and related usage instructions?
2026-02-01 22:25:32
Check Details
How many tablets of Febuxostat (Febuxostat) are recommended to be taken in a day to be safe and effective?
2026-02-01 22:25:32
Check Details
Furmonertinib official instructions and medication instructions for patients
2026-02-01 22:25:32
Check Details
Analysis of the clinical efficacy of ensifentrine-Ohtuvayre in the effective treatment of patients with chronic obstructive pulmonary disease
2026-02-01 22:25:32
Check Details
1
2
...
2113
2114
2115
2116
2117
2118
2119
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma